Discriminative stimulus control with olanzapine: Generalization to the atypical antipsychotic clozapine

Psychopharmacology

Volumn 128, Issue 2, 1996, Pages 216-219

  Porter, Joseph H ^a   Strong, Sarah E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

atypical antipsychotics; clozapine; drug discrimination; neuroleptics; olanzapine; rats

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS GENERALIZATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; CLOZAPINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029823279     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050127     Document Type: Article

References (26)

1. Bakshi VP, Geyer MA (1995) Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology 122: 198-201
2. Beasley JM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S and the Olanzapine HGAD Study Group (1996) Olanzapine versus placebo and haloperidol. Neuropharmacology 14: 111-123
3. Benvenga MJ, Leander JD (1995) Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons. Psychopharmacology 119: 133-138
4. Borison RL (1995) Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics. J Clin Psychopharmacol 15: 24S-29S
5. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14: 87-96
6. Bruning JL, Kintz BL (1977) Computational handbook of statistics, 2nd edn. Scott, Foresman and Company, Glenview, Illinois, pp 122-124
7. Casey DE (1989) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 99: S47-S53
8. Claghorn JL, Honigfeld G, Abuzzahab FS, Wang R, Steinbook R, Tuason V, Klerman GL (1987) The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7: 377-384
9. Cools AR, Prinssen EPM, Ellenbroek BA (1995) The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine. Psychopharmacology 119: 428-439
10. Das S, Fowler SC (1995) Acute and subchronic effects of clozapine on licking in rats: tolerance to disruptive effects on number of licks, but no tolerance to rhythm slowing. Psychopharmacology 120: 249-255
11. Das S, Fowler SC (1996) Similarity of clozapine's and olanzapine's acute effects on rat's lapping behavior. Psychopharmacology 123: 374-378
12. Ellenbroek BA, Peeters BW, Honig WM, Cools AR (1987) The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs. Psychopharmacology 93: 343-348
13. Extance K, Goudie A (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73: 363-371
14. Faustman WO, Fowler SC (1981) Use of response duration to distinguish the effect of haloperidol from nonreward. Pharmcol Biochem Behav 15: 327-329
15. Fowler SC, Filewich RJ, Leberer MR (1977) Drug effects upon force and duration of response during fixed-ratio performance in rats. Pharmacol Biochem Behav 6: 421-426
16. Franklin SR, Tang AH (1994) Discriminative stimulus effects of clozapine in rats. Behav Pharmacol 5: 113
17. Goas JA, Boston JE (1978) Discriminative stimulus properties of clozapine and chlorpromazine. Pharmacol Biochem Behav 8: 235-241
18. Harris RT, Balster RL (1971) An analysis of the function of drugs in the stimulus control of operant behavior. In: Thompson T, Pickens R (eds) Stimulus properties of drugs. Meredith, New York, N.Y., pp 111-132
19. Kaempf GL, Porter JH (1997) Differential effects of pimozide and clozapine on schedule-controlled and schedule-induced behavior after acute and chronic administration. J Pharmacol Exp Ther 243: 437-445
20. Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262: 545-551
21. Moore NA, Calligaro DO, Wong DT, Bymaster F, Tye NC (1993) The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Invest Drugs 2: 281-293
22. Porter JH, Villanueva HF (1988) Assessment of pimozide's motor and hedonic effects on operant behavior in rats. Pharmacol Biochem Behav 31: 779-786
23. Varvel SA, Strong SE, Floyd CL, Haag KJ, Porter JH (1996) A comparison of olanzapine with typical and atypical antipsychotics in the paw test. Proceedings and Abstracts of the Annual Meeting of the Eastern Psychological Association 67: 60
24. Villanueva HF, Porter JH (1993) Differential tolerance to the behavioral effects of chronic pimozide and clozapine on multiple random interval responding in rats. Behav Pharmacol 4: 201-208
25. Wiley JL, Porter JH (1992) Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacol Biochem Behav 43: 961-965
26. Wiley JL, Compton AD, Porter JH (1994) Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing. Pharmacol Biochem Behav 48: 253-257